aut00206
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02589262)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aut00206
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03164876 | Phase 1 | Apr 20, 2017 | Autifony Therapeutics Limited, University of London |
| NCT02935725 | Phase 1 | Sep 1, 2016 | Autifony Therapeutics Limited, University of Manchester |
| NCT02589262 | Phase 1 | Sep 1, 2015 | Autifony Therapeutics Limited |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Autifony Therapeutics Limited | For profit | 3 | 3 | 1 | 2015 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Manchester | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1